FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is using the cannabinoid substance HU-210 as an agent simulating postconditioning. It is shown that a myocardial necrotic zone tends to decrease both absolutely, and as a percentage of an infarction zone to a hypoperfusion zone.
EFFECT: invention may be used to create a new effective agent simulating cardiac postconditioning.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT IMPROVING BLOOD SUPPLY AND MYOCARDIAL METABOLISM | 2002 |
|
RU2225201C2 |
AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
METHOD FOR REDUCING THE SIZE OF ISCHEMIC-REPERFUSION MYOCARDIAL INJURY WITH THE USE OF QUINACRINE | 2019 |
|
RU2716596C1 |
AGENT WITH CARDIOPROTECTIVE ACTIVITY | 2019 |
|
RU2791641C2 |
METHOD FOR SIMULATION OF INCREASED STABILITY OF RAT MYOCARDIUM TO ISCHEMIC-REPERFUSION DAMAGE | 2016 |
|
RU2623727C1 |
AGENT POSSESSING CARDIOPROTECTIVE ACTIVITY | 2019 |
|
RU2699039C1 |
ANTI-ARRHYTHMIC AGENT | 2001 |
|
RU2195275C1 |
IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
Authors
Dates
2013-12-27—Published
2012-10-25—Filed